Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...
Adaptive Biotechnologies plans to release its complete fourth quarter and full year 2025 financial results during its earnings call in February 2026. 1 Excludes Digital Biotechnologies, Inc. cash and ...
SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune ...
Drawing inspiration from the remarkable adaptability of the human eye, researchers from the Institute of Metal Research (IMR) ...
New Study Shows SIK1 Strengthens Antiviral Immunity to Limit EV-D68–Induced Asthma Exacerbations Asthma is a chronic ...
Adaptive Biotechnologies ( ($ADPT) ) has issued an announcement. On December 30, 2025, Adaptive Biotechnologies announced that its 70%-owned ...
Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...
A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...
But in the 1990s the virus that causes AIDS turned out to offer a solution. Researchers discovered how to strip away HIV’s destructive genes and repurpose it as a “lentiviral vector”—a tool to deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback